Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.


Profile: change is the only constant for Quilter Cheviot

This is not the first time we have profiled David Miller, but at the time of his previous appearance his company looked very different.

Profile: from Batman Live to commodity beta

Charteris may be a family affair, but the company is not at any risk of turning sentimental

Profile: Scalable Capital is the name, but not the challenge

Changing the face of financial services is clearly the goal at Scalable Capital

Profile: building the four pillars of Progeny Group

The Leeds-based former adviser has retooled as a full-spectrum wealth firm in recent years, and now has big plans for expansion

Profile: MoneyFarm's CEO on creatively disrupting wealth

Moneyfarm is on a mission to disrupt wealth management, but many of its challenges are likely to be relatable to the old school

Profile: 'a lot of the hard work is done' says Charles Stanley

We’ve turned a corner, and there is positive momentum behind Charles Stanley says Charles Stanley's private client head

Profile: why Patronus Partners' founder left the only job he ever knew

'There was a definite idea of how things would work out over 12 months. When we look back, that was inaccurate'

Cover Star Club: the wealth managers we grilled in 2016 - Part 2

The highlights from the wealth managers we profiled in the second half of 2016.

Cover Star Club: the wealth managers we grilled in 2016 - part 1

In the first of a two part series, we run through the wealth managers we profiled in the first half of 2016.  

Profile: meet the last romantic of wealth management

The chief investment officer of LJ Partnership stands out among his peers for his rejection of operative efficiency as an end in itself

Investment Trust video
Play James Henderson's HOT trades post-Brexit

James Henderson's HOT trades post-Brexit

James Henderson, the manager of the Henderson Opportunities Trust has been finding opportunities to invest since the summer, especially in the pharmaceuticals sector.